ConductScience.org, home

Trial · NCT07884786

Registered outcomes11

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange in Postural SwayBaseline and Week 6Changes in anteroposterior and mediolateral postural sway measured using the Bertec Balance Legacy System under eyes-open and eyes-closed conditions on firm and foam surfaces.
SecondaryChange in Limits of StabilityBaseline and Week 6Anterior, posterior, right, left, and total limits of stability obtained from the Bertec Balance Legacy System.
SecondaryChange in Postural AlignmentBaseline and Week 6PostureScreenMobile-derived anterior cervical tilt, shoulder alignment, and other posture measures; displacements reported in centimeters.
SecondaryChange in Cervical Range of MotionBaseline and Week 6Active and passive cervical flexion/extension, lateral flexion and rotation assessed with a universal goniometer in degrees.
SecondaryChange in Cervical and Scapular Muscle StrengthBaseline and Week 6Cervical flexor/extensor and upper/middle/lower trapezius isometric force measured by dynamometry in newtons.
SecondaryChange in Cervical Muscle Activation by sEMGBaseline and Week 6Right and left sternocleidomastoid and upper trapezius surface electromyography; root mean square activity in microvolts, analyzed during a 5-second maximum voluntary contraction.
SecondaryChange in Dynamic Gait Index ScoreBaseline and Week 6Eight walking and functional gait activities, total score 0-24; higher scores indicate better performance.
SecondaryChange in Vertigo Symptom Scale-Short Form ScoreBaseline and Week 615-item symptom questionnaire with item responses from 0 to 4, including vestibular and anxiety-related symptom dimensions.
SecondaryChange in Dizziness Handicap Inventory ScoreBaseline and Week 625-item questionnaire with a total score of 0-100; higher scores indicate greater dizziness-related handicap.
SecondaryChange in Dizziness SeverityBaseline and Week 6Participant-reported dizziness intensity measured using a 0-10 visual analogue scale.
SecondaryChange in Neck Pain SeverityBaseline and Week 6Participant-reported neck pain intensity measured using a 0-10 visual analogue scale when pain is present.

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07884786/registered